Home » Sulfonylureas Risk Versus Metformin Points to Clear First-Line Diabetes Choice
Sulfonylureas Risk Versus Metformin Points to Clear First-Line Diabetes Choice
Using sulfonylureas as a first-line treatment for diabetes is associated with an increased risk for cardiovascular disease events or death compared with the use of metformin, research shows.
medwire News
medwire News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May